KITLG and cancer: As cancer promoters, they produce different pro-angiogenic molecules such as VEGF-A, VEGF-B, FGF, heparin, stem cell factor (SCF), etc. [207,208,209,210]; on the other hand, MCs have anti-tumor effects.